Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index; 1 of the 26 sources its claims cite were checked for support.
Abstract
Purpose: The incidence of esophageal adenocarcinoma (EAC) has risen substantially in recent decades, while the average 5-year survival remains only ~20%. Disease stage and treatment are the strongest prognostic factors. The role of lifestyle factors in relation to survival remains uncertain, with a handful of studies to date investigating associations with obesity, smoking, physical activity, diet, or medications. Methods: This study included patients diagnosed with primary adenocarcinoma of the esophagus, gastroesophageal junction, or cardia (N = 371) at Roswell Park Comprehensive Cancer Center between 2003 and 2019. Leveraging extensive data abstracted from electronic medical records, epidemiologic questionnaires, and a tumor registry, we analyzed clinical, behavioral, and environmental exposures and evaluated stage-specific associations with survival. Survival distributions were visualized using Kaplan–Meier curves. Cox proportional hazards regression models adjusted for age, sex, stage, treatment, and comorbidities were used to estimate the association between each exposure and all-cause or cancer-specific mortality. Results: Among patients presenting with localized/regional tumors (stages I–III), current smoking was associated with increased overall mortality risk (HR = 2.5 [1.42–4.53], p = 0.002), while current physical activity was linked to reduced risk (HR = 0.58 [0.35–0.96], p = 0.035). Among patients with stage IV disease, individuals reporting pre-diagnostic use of statins (HR = 0.62 [0.42–0.92], p = 0.018) or NSAIDs (HR = 0.61 [0.42–0.91], p = 0.016) had improved overall survival. Exploratory analyses suggested that high pre-diagnostic dietary consumption of broccoli, carrots, and fiber correlated with prolonged overall survival in patients with localized/regional disease. Conclusion: Our data suggest that lifestyle exposures may be differentially associated with EAC survival based on disease stage. Future investigation of larger, diverse patient cohorts is essential to validate these findings. Our results may help inform the development of lifestyle-based interventions to improve EAC prognosis and quality of life.
Overview
CoChat Summary
## TL;DR
This retrospective cohort study of 371 esophageal adenocarcinoma patients at Roswell Park found that survival associations differed by stage: current smoking and current inactivity were linked to worse outcomes in localized/regional disease, while pre-diagnostic statin and NSAID use were linked to better survival in stage IV disease. Exploratory analyses also suggested better survival with higher intake of broccoli, carrots, and fiber among localized/regional cases.
## Key findings
- Among patients with localized/regional disease (stage I–III), current smokers had a 2.5-fold higher all-cause mortality risk than never smokers (HR = 2.5, 95% CI 1.42–4.53; p = 0.002).
- In localized/regional disease, current physical activity was associated with lower all-cause mortality risk (HR = 0.58, 95% CI 0.35–0.96; p = 0.035).
- Among stage IV patients, pre-diagnostic statin use was associated with lower all-cause mortality (HR = 0.62, 95% CI 0.42–0.92; p = 0.018), and pre-diagnostic NSAID use was also associated with lower all-cause mortality (HR = 0.61, 95% CI 0.42–0.91; p = 0.016).
- Exploratory dietary analyses in localized/regional disease found reduced all-cause mortality with >3 servings/month of broccoli and carrots, and with >18.6 g/day of fiber; the paper reports 47% and 62% reduced risk for broccoli and carrots, respectively, and 66% reduced risk for higher fiber intake.
## Methods
- Retrospective cohort of 371 patients with newly diagnosed histologically confirmed primary adenocarcinoma of the esophagus, gastroesophageal junction, or cardia, treated at Roswell Park Comprehensive Cancer Center; participants enrolled in the DBBR between January 2003 and September 2019.
- Data came from electronic medical records, the Roswell Park Tumor Registry, and DBBR questionnaires; outcomes were all-cause survival and esophageal cancer-specific survival through September 2019.
- Kaplan–Meier curves and Cox proportional hazards models were used, with multivariable adjustment for age, sex, stage, treatment, and comorbidities; analyses were stratified into localized/regional (stages I–III) and advanced/metastatic (stage IV) disease.
## Limitations
- The paper states that exposure ascertainment from the EMR and questionnaire is subject to measurement error, recall bias, inaccuracies in records, and abstraction errors.
- It notes possible selection bias because DBBR participation was voluntary, and limited generalizability because most patients were White and treated at a comprehensive cancer center.
- The paper also states that lack of post-diagnostic information (for example, weight change, smoking cessation, physical activity, diet, and medications) may have caused residual confounding.
- Evident from the text: some exposure data were available only for subsets of participants, including physical activity for 173 participants and dietary analysis restricted to localized/regional tumors, which limits precision and completeness.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
1 Valid · 1 Not valid · 9 Not checked · 33 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, pre-diagnostic MVPA did correlate with improved cancer-specific survival (HR = 0.41, p = 0.04), among patients with localized/regional tumors.”
§ Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center > 4. Discussion
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI at diagnosis, history of alcohol consumption, medication use, and pre-diagnostic MVPA were not associated with OS.”
- Also stated in: § 4. Discussion · plain
“Consistent with results of prior studies, stage and treatment were strong prognostic factors in our analyses, while alcohol consumption was not associated with survival [12,13,16,18,19].”
§ Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center > 3. Results > 3.2. Localized/Regional Tumors
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 4. Discussion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, no survival associations were identified for modifiable lifestyle exposures such as smoking, alcohol consumption, BMI at diagnosis, and physical activity, or for use of anti-reflux medications.”
§ Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center > 3. Results > 3.3. Advanced/Metastatic Tumors
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Among patients with stage IV disease, individuals reporting pre-diagnostic use of statins (HR = 0.62 [0.42–0.92], p = 0.018) or NSAIDs (HR = 0.61 [0.42–0.91], p = 0.016) had improved overall survival.”
- Also stated in: § 3.3. Advanced/Metastatic Tumors · plain
“Interestingly, patients reporting pre-diagnostic use of statins had a 38% reduced risk of all-cause mortality compared to statin non-users (HR = 0.62 [0.42–0.92], p = 0.018).”
- Also stated in: § 4. Discussion · plain
“By contrast, among patients with stage IV tumors, pre-diagnostic use of statins or NSAIDs was associated with increased overall and cancer-specific survival.”
§ Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center > Abstract > Abstract Purpose: The incidence of esophageal adenocarcinoma (EAC) has risen substantially in recent decades, while the average 5-year survival remains only ~20%. Disease stage and treatment are the strongest prognostic factors. The role of lifestyle factors in relation to survival remains uncertain, with a handful of studies to date investigating associations with obesity, smoking, physical activity, diet, or medications. Methods: This study included patients diagnosed with primary adenocarcinoma of the esophagus, gastroesophageal junction, or cardia (N = 371) at Roswell Park Comprehensive Cancer Center between 2003 and 2019. Leveraging extensive data abstracted from electronic medical records, epidemiologic questionnaires, and a tumor registry, we analyzed clinical, behavioral, and environmental exposures and evaluated stage-specific associations with survival. Survival distributions were visualized using Kaplan–Meier curves. Cox proportional hazards regression models adjusted for age, sex, stage, treatment, and comorbidities were used to estimate the association between each exposure and all-cause or cancer-specific mortality. Results: Among patients presenting with localized/regional tumors (stages I–III), current smoking was associated with increased overall mortality risk (HR = 2.5 [1.42–4.53], p = 0.002), while current physical activity was linked to reduced risk (HR = 0.58 [0.35–0.96], p = 0.035). Among patients with stage IV disease, individuals reporting pre-diagnostic use of statins (HR = 0.62 [0.42–0.92], p = 0.018) or NSAIDs (HR = 0.61 [0.42–0.91], p = 0.016) had improved overall survival. Exploratory analyses suggested that high pre-diagnostic dietary consumption of broccoli, carrots, and fiber correlated with prolonged overall survival in patients with localized/regional disease. Conclusion: Our data suggest that lifestyle exposures may be differentially associated with EAC survival based on disease stage. Future investigation of larger, diverse patient cohorts is essential to validate these findings. Our results may help inform the development of lifestyle-based interventions to improve EAC prognosis and quality of life.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.3. Advanced/Metastatic Tumors · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Similar results were obtained when analyzing cancer-specific mortality (Table S5).”
- Also stated in: § 4. Discussion · plain
“By contrast, among patients with stage IV tumors, pre-diagnostic use of statins or NSAIDs was associated with increased overall and cancer-specific survival.”
§ Clinical and Lifestyle-Related Prognostic Indicators among Esophageal Adenocarcinoma Patients Receiving Treatment at a Comprehensive Cancer Center > 3. Results > 3.3. Advanced/Metastatic Tumors
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 4. Discussion · plain
20 more claims
Create a free account to see all 44 claims and to verify the 25 references still open.
- Probably not a substantial claim. 9
- The quote only partly states this claim. 7
- It may state two separate claims as one. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An increasing number of studies have shown that low to moderate-intensity exercises could help cancer patients to recover, deal with treatment, and also have an impact on extending survival time [2,3,4,5].”
From The Effect of Vinyasa Yoga Practice on the Well-Being of Breast-Cancer Patients during COVID-19 Pandemic (2023) · cites this paper as [3]
Experimental — accuracy not yet measured
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Harris, P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., & Conde, J. G. (2009) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2008.08.010 · Cited by 51,384 · cited 1×
“REDCap is a secure, web-based software platform designed to support data capture for research studies [59].”
MethodPennathur, A., Gibson, M. K., Jobe, B. A., & Luketich, J. D. (2013) · The Lancet · doi:10.1016/s0140-6736(12)60643-6 · Cited by 2,390 · cited 1×
“Esophageal cancer, a relatively rare yet lethal malignancy, has a dismal average 5-year survival rate of only ~20% [1].”
BackgroundSjoquist, K. M., Burmeister, B. H., Smithers, B. M., Zalcberg, J. R., Simes, R. J., Barbour, A., & Gebski, V. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70142-5 · Cited by 1,647 · cited 1×
“Neoadjuvant therapy prior to surgery has become the standard-of-care for resectable tumors, providing a significant survival advantage relative to surgery alone [14,15].”
BackgroundUSDA National Nutrient Database for Standard Reference, Release 22
(2018) · Cited by 1,285
Smyth, E. C., Lagergren, J., Fitzgerald, R. C., Lordick, F., Shah, M. A., Lagergren, P., & Cunningham, D. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.48 · Cited by 1,012
Mechanisms linking physical activity with cancer
McTiernan, A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2325 · Cited by 744 · cited 1×
“Biological mechanisms underlying associations between PA and cancer survival are under active investigation and may include reduced chronic inflammation and improved insulin sensitivity, metabolic function, and immune surveillance [25,40,41].”
BackgroundFriedenreich, C. M., Ryder‐Burbidge, C., & McNeil, J. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12772 · Cited by 661 · cited 1×
“Biological mechanisms underlying associations between PA and cancer survival are under active investigation and may include reduced chronic inflammation and improved insulin sensitivity, metabolic function, and immune surveillance [25,40,41].”
BackgroundBody Mass Index and Risk of Adenocarcinomas of the Esophagus and Gastric Cardia
Chow, W.-H., Blot, W. J., Vaughan, T. L., Risch, H. A., Gammon, M. D., Stanford, J. L., Dubrow, R., Schoenberg, J. B., Mayne, S. T., Farrow, D. C., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.2.150 · Cited by 626 · cited 3×
“Gastroesophageal reflux (GERD), central obesity, smoking, male sex, and inherited genetics are established risk factors for EAC and its precursor, Barrett’s esophagus (BE) [5–9].”
BackgroundThe Epidemiology of Esophageal Adenocarcinoma
Coleman, H. G., Xie, S.-H., & Lagergren, J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.07.046 · Cited by 549
Research works printed but not linked: 1
- Rosen, R.D., and Sapra, A. (2021, January 06). TNM Classification, StatPearls [Internet], Available online: https://www.ncbi.nlm.nih.gov/books/NBK553187/.
Cited by
Exploring the Impact of the Obesity Paradox on Lung Cancer and Other Malignancies
Nitsche, L., Mukherjee, S., Cheruvu, K., Krabak, C., Rachala, R., Ratnakaram, K., Sharma, P., Singh, M., & Yendamuri, S. (2022) · Cancers · doi:10.3390/cancers14061440 · Cited by 53
“Statins have improved overall survival in stage four esophageal cancer patients [157].”
BackgroundSelf-citationZhou, Q., Jiao, Z., Liu, Y., Devreotes, P. N., & Zhang, Z. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1234713 · Cited by 31
Zok, A., Matecka, M., Zapala, J., Izycki, D., & Baum, E. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20043770 · Cited by 13
Gastroesophageal disease risk and inhalational exposure a systematic review and meta-analysis
Kim, D. H., PODURY, S., Zadeh, A. F., Mahmoodi, T., Kwon, S., Grünig, G., Liu, M., & Nolan, A. (2025) · Scientific Reports · doi:10.1038/s41598-025-06620-7 · Cited by 10
MiR ‐671‐5p sponging activity of circMMP1 promotes esophageal squamous cancer progression
Li, R., Chai, L., Lei, L., Guo, R., & Wen, X. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.15078 · Cited by 9
“It is estimated that less than 30% of ESCC patients survive 5 years despite multidisciplinary therapy.(4) With the advent of precision medicine, revealing the pathogenesis of cancer at the molecular level and targeting therapy for patients have become an important development direction of tumor therapy.”
BackgroundMenon, S., Norman, R., Iyer, P. G., & Ragunath, K. (2024) · Endoscopy · doi:10.1055/a-2317-8184 · Cited by 7
The association between statin use and prognosis in esophageal cancer patients: A meta-analysis
Lv, J., Chen, P., Wu, J., Zhi, W., & Zhao, C. (2023) · Medicine · doi:10.1097/md.0000000000033359 · Cited by 6
“Alexandre([18]) 1 1 1 1 0 1 1 1 7 Cardwell([19]) 1 1 1 1 1 1 1 1 8 Nguyen([20]) 1 1 1 1 0 1 1 1 7 Lacroix([21]) 1 1 1 1 0 1 1 1 7 Dighe([22]) 1 1 1 1 0 1 1 0 6 Abdelfatah([23]) 1 1 1 1 0 1 1 1 7 Kim([24]) 1 1 1 1 1 1 1 1 8”
BackgroundFukushima, T., Watanabe, N., Okita, Y., Yokota, S., Kurita, D., Ishiyama, K., Oguma, J., Kawai, A., & Daiko, H. (2023) · General Thoracic and Cardiovascular Surgery · doi:10.1007/s11748-023-01977-w · Cited by 6
“While a previous report has found no significant association between physical activity and mortality in esophageal cancer [29], a significant association has been shown between postoperative physical activity, physical activity after various treatment settings, and mortality [30, 31].”
Metadata
- Authors
- Dighe, S. G., Yan, L., Mukherjee, S., McGillicuddy, C. S., Hulme, K. L., Hochwald, S. N., Yendamuri, S., Bain, A. J., Robillard, K. T., Moysich, K. B., Ambrosone, C. B., Millen, A. E., & Buas, M. F.
- Affiliations
- Roswell Park Comprehensive Cancer Center (US)
- University at Buffalo, State University of New York (US)
- Corresponding author
- Dighe, Shruti G.
- Buas, Matthew F.
- ORCID
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2021-09-16
- Volume
- 13
- Issue
- 18
- Pages
- 4653
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC8465866
- OpenAlex
- W3200933658
- Cited by
- 8
- References
- 58
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 5 · 2022: 1
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Cancer Institute (P30CA016056)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- esophageal adenocarcinoma, gastroesophageal junction cancer, gastric cardia cancer, prognostic factors, survival, lifestyle factors, smoking, physical activity, statins, nonsteroidal anti-inflammatory drugs, dietary fiber, broccoli, carrot, disease stage, cancer-specific mortality, all-cause mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

